Shuo R. Li
Changchun, 130033, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
High-intensity interval training and moderate-intensity continuous training are effective, feasible, and safe for patients with metabolic dysfunction-associated steatotic liver disease (MASLD): A systematic review and meta-analysis.
Journal: Metabolism: clinical and experimental
Published: December 26, 2025
Extending the Temperature and Time Operating Windows of CsPbI3 Quantum Dots for Scalable Synthesis for LEDs.
Journal: Angewandte Chemie (International ed. in English)
Published: December 10, 2025
Energetic Disorder Mitigation of Hole-Transport Layers via Molecular Assembly Boosts Charge Transport to Unlock Efficient and Stable Perovskite Light-Emitting Devices.
Journal: Nano letters
Published: November 23, 2025
Ligand and Stoichiometry Engineering Unlock Narrowband Red Emission in Colloidal PEA2SnI4 Nanoplatelets.
Journal: Inorganic chemistry
Published: June 23, 2025
Use of CsPbCl3 Quantum Dots as a Chlorine Source Enables Formation of Thick Quasi-2D Perovskite Films for High-Performance Blue Light Emitting Diodes.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: April 12, 2025
Reprogramming cellular senescence of hepatic stellate cells to combat liver fibrosis by targeted nanodrugs.
Journal: Materials today. Bio
Published: February 15, 2025
Biomimetic Nanovaccines Restore Immunosuppressive Tumor Antigen-Presenting Cells via the Saposin-Feeding Strategy.
Journal: ACS biomaterials science & engineering
Published: November 19, 2024
Controlling the wavefront aberration of a large-aperture and high-precision holographic diffraction grating.
Journal: Light, science & applications
Published: November 17, 2024
Druggable genome-wide Mendelian randomization identifies therapeutic targets for metabolic dysfunction-associated steatotic liver disease.
Journal: Lipids in health and disease
Published: November 06, 2024
Dual-targeted siRubicon delivery strategy triggers hepatocellular lipophagy for mitigating liver steatosis.
Journal: Nature communications
Published: July 22, 2024
Leveraging adrenergic receptor blockade for enhanced nonalcoholic fatty liver disease treatment via a biomimetic nanoplatform.
Journal: Journal of nanobiotechnology
Published: April 25, 2024
Last Updated: 09/26/2026